Since MAPK signaling pathway includes some well known glioblastoma pathogenic genes, such as EGFR [40]and PDGFR [41], changes in signal transduction of this pathway could have an important impact on gliomagenesis. The gene discussed is EGFR; the disease is glioblastoma.